Durect Corporation Total Liabilities
Durect Corporation total liabilities. Based on the latest financial reports, Durect Corporation (DRRX) has total liabilities worth $8.54 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Durect Corporation to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Durect Corporation (1999–2024)
Total liabilities of Durect Corporation from 1999 to 2024. This chart illustrates how Durect Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore DRRX long-term investment intensity to see how much of total assets are deployed in long-term investments.
Durect Corporation Competitors by Total Liabilities
The table below lists competitors of Durect Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ageagle Aerial Systems Inc
NYSE MKT:UAVS
|
USA | $6.49 Million |
|
Aztek Teknoloji Urunleri Ticaret A.S.
IS:AZTEK
|
Turkey | TL2.90 Billion |
|
Oriental Food Industries Hold
KLSE:7107
|
Malaysia | RM78.50 Million |
|
Nebag ag
SW:NBEN
|
Switzerland | CHF91.85K |
|
iLearningEngines, Inc.
NASDAQ:AILE
|
USA | $153.76 Million |
|
Principal Real Estate Income Closed Fund
NYSE:PGZ
|
USA | $34.84 Million |
|
Comtrend Corp
TWO:8089
|
Taiwan | NT$542.26 Million |
|
Newfield Resources Ltd
AU:NWF
|
Australia | AU$15.64 Million |
Liability Composition Analysis (1999–2024)
This chart breaks down Durect Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Durect Corporation's balance sheet.
Liquidity & Leverage Metrics
Durect Corporation Total Liabilities Ratios Explained
Durect Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.68 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Durect Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Durect Corporation (1999–2024)
The table below shows the annual total liabilities of Durect Corporation from 1999 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $9.22 Million | -69.68% |
| 2023-12-31 | $30.41 Million | -13.41% |
| 2022-12-31 | $35.12 Million | +2.65% |
| 2021-12-31 | $34.21 Million | -3.71% |
| 2020-12-31 | $35.53 Million | -43.75% |
| 2019-12-31 | $63.16 Million | +110.54% |
| 2018-12-31 | $30.00 Million | -5.14% |
| 2017-12-31 | $31.62 Million | -1.69% |
| 2016-12-31 | $32.17 Million | +0.88% |
| 2015-12-31 | $31.89 Million | +1.01% |
| 2014-12-31 | $31.57 Million | +212.60% |
| 2013-12-31 | $10.10 Million | +5.15% |
| 2012-12-31 | $9.60 Million | -78.99% |
| 2011-12-31 | $45.72 Million | -13.86% |
| 2010-12-31 | $53.07 Million | +72.68% |
| 2009-12-31 | $30.73 Million | -20.08% |
| 2008-12-31 | $38.45 Million | -22.22% |
| 2007-12-31 | $49.44 Million | -24.47% |
| 2006-12-31 | $65.45 Million | -11.62% |
| 2005-12-31 | $74.06 Million | +10.41% |
| 2004-12-31 | $67.08 Million | -0.32% |
| 2003-12-31 | $67.29 Million | +891.19% |
| 2002-12-31 | $6.79 Million | -14.01% |
| 2001-12-31 | $7.89 Million | +47.35% |
| 2000-12-31 | $5.36 Million | +208.82% |
| 1999-12-31 | $1.74 Million | -- |
About Durect Corporation
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment… Read more